Information on therapeutic neuromodulation in psychiatry
Jul 13, 2011
BROADEN Study on DBS for Depression by St. Jude to be expanded
The FDA has allowed St. Jude to expand its BROADEN study to up to 20 study centers across the US with a total of 125 patients, the company has announced that they later request approval to further expand the study to a total of 231 patients. You nan read the press release of the company here.